Return of gene therapy: How to make the treatment safer
At the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston, Massachusetts, viral immunologist Ying Kai Chan is trying to develop safer AAV vectors. The risks increased when researchers used larger amounts of AAV, he told the conference: “I’m a big fan of reducing the dose.” But this may require the development of […]
Butantan Institute begins study | podcast
Even if 30% of those infected do not show symptoms, the disease can leave serious sequelae. At the end of January, the Butantan Institute began the clinical trial of the vaccine against the chikungunya virus, in partnership with the pharmaceutical company Valneva Austria GmbH. It is, so far, the only vaccine that has reached phase […]